Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction
暂无分享,去创建一个
Daniel T. Chang | Michael-Rock Goldsmith | Rogelio Tornero-Velez | Curtis C. Dary | Christopher M. Grulke | Yu-Mei Tan | Jingtao Lu | Raina D. Brooks | Jeremy A. Leonard | Martin B. Phillips | Ethan D. Hypes | Matthew J. Fair | Jeffre Johnson | C. Grulke | Y. Tan | D. Chang | R. Tornero-Velez | M. Goldsmith | C. Dary | Jingtao Lu | J. Leonard | M. Phillips | Jeffre C. Johnson | R. Brooks
[1] Robert P. Sheridan,et al. Chemical Similarity Using Physiochemical Property Descriptors , 1996, J. Chem. Inf. Comput. Sci..
[2] M E Andersen,et al. Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk. , 2001, Inhalation toxicology.
[3] Harvey J Clewell,et al. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling , 2007, Journal of Exposure Science and Environmental Epidemiology.
[4] Robert C. Glen,et al. Cytochrome P450 site of metabolism prediction from 2D topological fingerprints using GPU accelerated probabilistic classifiers , 2014, Journal of Cheminformatics.
[5] Franco Lombardo,et al. Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds , 2008, Drug Metabolism and Disposition.
[6] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[7] George Chang,et al. Assessment of in silico models for fraction of unbound drug in human liver microsomes , 2010, Expert opinion on drug metabolism & toxicology.
[8] C J Portier,et al. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. II. Rates of metabolism. , 1998, Toxicology and applied pharmacology.
[9] Jeffrey W Fisher,et al. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. , 2011, Toxicology and applied pharmacology.
[10] S. Pierson,et al. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[11] M Rowland,et al. Tissue distribution and physiologically based pharmacokinetics of antisense phosphorothioate oligonucleotide ISIS 1082 in rat. , 2001, Antisense & nucleic acid drug development.
[12] David Ashley,et al. Dermal, oral, and inhalation pharmacokinetics of methyl tertiary butyl ether (MTBE) in human volunteers. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[13] Tycho Heimbach,et al. Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.
[14] H J Clewell,et al. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. , 1991, Toxicology and applied pharmacology.
[15] Harvey J. Clewell,et al. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[16] Jan Snoeys,et al. From preclinical to human – prediction of oral absorption and drug–drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example , 2012, Biopharmaceutics & drug disposition.
[17] J Meulenbelt,et al. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. , 2001, Toxicology and applied pharmacology.
[18] Irini Doytchinova,et al. Quantitative structure--plasma protein binding relationships of acidic drugs. , 2012, Journal of pharmaceutical sciences.
[19] K Krishnan,et al. A Spreadsheet Program for Modeling Quantitative Structure-Pharmacokinetic Relationships for Inhaled Volatile Organics in Humans , 2005, SAR and QSAR in environmental research.
[20] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[21] Rocky Goldsmith,et al. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment. , 2012, Reviews of environmental contamination and toxicology.
[22] J. Gallo,et al. Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib , 2009, Molecular Cancer Therapeutics.
[23] Curtis C Dary,et al. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[24] Ryo Shimizu,et al. QSAR application for the prediction of compound permeability with in silico descriptors in practical use , 2009, J. Comput. Aided Mol. Des..
[25] R B Conolly,et al. Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments. , 1995, Toxicology letters.
[26] M. Rowland,et al. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. , 2006, Journal of pharmaceutical sciences.
[27] Tudor I. Oprea,et al. Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..
[28] P L Bonate,et al. Preliminary physiologically based pharmacokinetic model for cocaine in the rat: model development and scale-up to humans. , 1996, Journal of pharmaceutical sciences.
[29] Franco Lombardo,et al. Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance , 2013, Journal of clinical pharmacology.
[30] C DeRosa,et al. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. , 1997, Toxicology and applied pharmacology.
[31] Melvin E. Andersen,et al. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate , 1990 .
[32] R Tardif,et al. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[33] L Aarons,et al. Population pharmacokinetics. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[34] Michael-Rock Goldsmith,et al. A pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[35] R Tardif,et al. Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures. , 2000, Toxicology and applied pharmacology.
[36] Franco Lombardo,et al. Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State , 2013, Journal of clinical pharmacology.
[37] Malcolm Rowland,et al. Physiologically-based pharmacokinetics in drug development and regulatory science. , 2011, Annual review of pharmacology and toxicology.
[38] K Krishnan,et al. An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. , 1995, Journal of toxicology and environmental health.
[39] Corie A Ellison,et al. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion. , 2011, Toxicology.
[40] Yu-Mei Tan,et al. Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[41] Ronald E. Baynes,et al. Carcass Vcarcass Vliver Vkidney Ccarcass Cliver Vplasma Cplasma Ckidney Qcarcass Qtot Carterial Qliver Qkidney Liver Kidney Urine Plasma IV Dose PO Dose LiverStomach , 2008 .
[42] Trevor N Brown,et al. General model for estimating partition coefficients to organisms and their tissues using the biological compositions and polyparameter linear free energy relationships. , 2013, Environmental science & technology.
[43] E. Hubal,et al. Exposure-based prioritization of chemicals for risk assessment , 2011 .
[44] Jeffery M Gearhart,et al. Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability. , 2014, Journal of pharmaceutical sciences.
[45] Kairui Feng,et al. The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance , 2013, In Silico Pharmacology.
[46] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[47] Vijay K. Gombar,et al. Quantitative Structure − Activity Relationship Models of Clinical Pharmacokinetics : Clearance and Volume of Distribution , 2013 .
[48] Daniel T. Chang,et al. DockScreen: A Database of In Silico Biomolecular Interactions to Support Computational Toxicology , 2014 .
[49] Markus J. Herrgård,et al. Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.
[50] Jeffrey W Fisher,et al. Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model. , 2013, Toxicology and applied pharmacology.
[51] Paul S Price,et al. Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues. , 2011, Regulatory toxicology and pharmacology : RTP.
[52] Patrick Bultinck,et al. Quantum Similarity Superposition Algorithm (QSSA): A Consistent Scheme for Molecular Alignment and Molecular Similarity Based on Quantum Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[53] C B Frederick,et al. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. , 1998, Toxicology and applied pharmacology.
[54] R Tardif,et al. Physiologically based modeling of p‐tert‐octylphenol kinetics following intravenous, oral or subcutaneous exposure in male and female Sprague–Dawley rats , 2010, Journal of applied toxicology : JAT.
[55] Melvin E Andersen,et al. Route-specific differences in distribution characteristics of octamethylcyclotetrasiloxane in rats: analysis using PBPK models. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[56] Anthony J Williams,et al. Public chemical compound databases. , 2008, Current opinion in drug discovery & development.
[57] S M Hays,et al. A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling. , 1997, Environmental health perspectives.
[58] G. Csanády,et al. The relevance of physical activity for the kinetics of inhaled gaseous substances , 2000, Archives of Toxicology.
[59] A Vinegar,et al. Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling. , 2000, Inhalation toxicology.
[60] Patrick Poulin,et al. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. , 2002, Journal of pharmaceutical sciences.
[61] R Tardif,et al. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. , 1997, Toxicology and applied pharmacology.
[62] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[63] Melvin E Andersen,et al. PBPK modeling of complex hydrocarbon mixtures: gasoline. , 2004, Environmental toxicology and pharmacology.
[64] John Cocker,et al. Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome P450s (CYP). , 2004, Toxicology letters.
[65] Andreas Bender,et al. Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms , 2012, J. Chem. Inf. Model..
[66] Stefan Willmann,et al. Theoretical Biology and Medical Modelling Open Access Dynamically Simulating the Interaction of Midazolam and the Cyp3a4 Inhibitor Itraconazole Using Individual Coupled Whole-body Physiologically-based Pharmacokinetic (wb-pbpk) Models , 2022 .
[67] Kannan Krishnan,et al. Molecular Structure-Based Prediction of the Partition Coefficients of Organic Chemicals for Physiological Pharmacokinetic Models , 1996 .
[68] Donald E Mager,et al. Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[69] Jianzhong Liu,et al. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis. , 2007, Molecular pharmaceutics.
[70] R. Tardif,et al. Comparison of the influence of binary mixtures versus a ternary mixture of inhaled aromatic hydrocarbons on their blood kinetics in the rat , 1996, Archives of Toxicology.
[71] Walter Schmitt,et al. General approach for the calculation of tissue to plasma partition coefficients. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.
[72] A W Kelman,et al. Population Pharmacokinetics Theory and Clinical Application , 1986, Clinical pharmacokinetics.
[73] Rebecca A Clewell,et al. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[74] P N Judson,et al. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.
[75] H J Clewell,et al. Pharmacodynamic model of the rat estrus cycle in relation to endocrine disruptors. , 1997, Journal of toxicology and environmental health.
[76] Thomas Peyret,et al. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. , 2010, Toxicology and applied pharmacology.
[77] Rogelio Tornero-Velez,et al. Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using a PBPK model. , 2010, Toxicology and applied pharmacology.
[78] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[79] C W Yap,et al. Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties. , 2007, Mini reviews in medicinal chemistry.
[80] Johann Gasteiger,et al. Ligand-Based Models for the Isoform Specificity of Cytochrome P450 3A4, 2D6, and 2C9 Substrates , 2007, J. Chem. Inf. Model..
[81] C. Tappert,et al. A Survey of Binary Similarity and Distance Measures , 2010 .
[82] Lisa M Sweeney,et al. Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats, rabbits, and humans , 2009, Inhalation toxicology.
[83] J. Heider,et al. Ethylbenzene Dehydrogenase, a Novel Hydrocarbon-oxidizing Molybdenum/Iron-Sulfur/Heme Enzyme* , 2001, The Journal of Biological Chemistry.
[84] Atsushi Kambayashi,et al. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[85] H. B. Matthews,et al. Using Structural Information to Create Physiologically Based Pharmacokinetic Models for All Polychlorinated Biphenyls: I. Tissue:Blood Partition Coefficients , 1997 .
[86] Rebecca A Clewell,et al. PBPK predictions of perchlorate distribution and its effect on thyroid uptake of radioiodide in the male rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[87] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[88] Josiah C. Hoskins,et al. Artificial neural network models for knowledge representation in chemical engineering , 1990 .
[89] F. Theil,et al. A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.
[90] Dolores Diaz,et al. An algorithm for evaluating potential tissue drug distribution in toxicology studies from readily available pharmacokinetic parameters. , 2013, Journal of pharmaceutical sciences.
[91] Taravat Ghafourian,et al. QSAR models for the prediction of plasma protein binding. , 2013, BioImpacts : BI.
[92] Vijay K. Agrawal,et al. Quantitative structure-pharmacokinetic relationship (QSPkP) analysis of the volume of distribution values of anti-infective agents from j group of the ATC classification in humans , 2012, Acta pharmaceutica.
[93] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[94] Jin Y. Jin,et al. A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer , 2013, Biopharmaceutics & drug disposition.
[95] P. Rutgeerts,et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. , 1997, Gut.
[96] Irini A. Doytchinova,et al. Quantitative structure--clearance relationships of acidic drugs. , 2013, Molecular pharmaceutics.
[97] Maurice Dickins,et al. Compound lipophilicity for substrate binding to human P450s in drug metabolism. , 2004, Drug discovery today.
[98] A A Kousba,et al. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon. , 2004, Neurotoxicology.
[99] Franco Lombardo,et al. Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds , 2018, Drug Metabolism and Disposition.
[100] C Timchalk,et al. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.